![Thomas D. Geracioti](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
James Randolph Hillard | M | - |
Phase 2 Discovery, Inc.
![]() Phase 2 Discovery, Inc. Pharmaceuticals: MajorHealth Technology Phase 2 Discovery, Inc. (P2D) develops central nervous system drugs. The company provides discovery research & development services for pharmaceutical and biotechnology companies. It also develops drugs for treating psychiatric and neurologic disorders. Its products include PD6735, the treatment of primary insomnia and additional indications, N-Substituted Analogs of Benztropine for the treatment of attention deficit hyperactivity disorder & Thiothalidomides and Hydroxythalidomides for the treatment of ALS and MS. Phase 2 Discovery was founded in 1998 and is headquartered in Cincinnati, OH. | - |
Thomas Dattilo | M | 72 |
RxDino LLC
![]() RxDino LLC Pharmaceuticals: MajorHealth Technology RxDino LLC operates as a dermatology pharmaceutical company. The firm develops skin products for the treatment of dermatitis, rash, eczema, itchy, irritated skin, and allergies to plants and chemicals, such as poison ivy. It provides Over-the-counter topical hydrocortisone ointment with a formulation containing dehydroepiandrosterone as an emollient that enables hydrocortisone to be effective. The company is headquartered in Cincinnati, OH. | - |
Gordon F. Brunner | M | 85 |
RxDino LLC
![]() RxDino LLC Pharmaceuticals: MajorHealth Technology RxDino LLC operates as a dermatology pharmaceutical company. The firm develops skin products for the treatment of dermatitis, rash, eczema, itchy, irritated skin, and allergies to plants and chemicals, such as poison ivy. It provides Over-the-counter topical hydrocortisone ointment with a formulation containing dehydroepiandrosterone as an emollient that enables hydrocortisone to be effective. The company is headquartered in Cincinnati, OH. | - |
Frank P. Zemlan | M | - |
Phase 2 Discovery, Inc.
![]() Phase 2 Discovery, Inc. Pharmaceuticals: MajorHealth Technology Phase 2 Discovery, Inc. (P2D) develops central nervous system drugs. The company provides discovery research & development services for pharmaceutical and biotechnology companies. It also develops drugs for treating psychiatric and neurologic disorders. Its products include PD6735, the treatment of primary insomnia and additional indications, N-Substituted Analogs of Benztropine for the treatment of attention deficit hyperactivity disorder & Thiothalidomides and Hydroxythalidomides for the treatment of ALS and MS. Phase 2 Discovery was founded in 1998 and is headquartered in Cincinnati, OH. | - |
Katherine Zanotti | F | 69 |
RxDino LLC
![]() RxDino LLC Pharmaceuticals: MajorHealth Technology RxDino LLC operates as a dermatology pharmaceutical company. The firm develops skin products for the treatment of dermatitis, rash, eczema, itchy, irritated skin, and allergies to plants and chemicals, such as poison ivy. It provides Over-the-counter topical hydrocortisone ointment with a formulation containing dehydroepiandrosterone as an emollient that enables hydrocortisone to be effective. The company is headquartered in Cincinnati, OH. | - |
Andrew Robell | M | - |
Phase 2 Discovery, Inc.
![]() Phase 2 Discovery, Inc. Pharmaceuticals: MajorHealth Technology Phase 2 Discovery, Inc. (P2D) develops central nervous system drugs. The company provides discovery research & development services for pharmaceutical and biotechnology companies. It also develops drugs for treating psychiatric and neurologic disorders. Its products include PD6735, the treatment of primary insomnia and additional indications, N-Substituted Analogs of Benztropine for the treatment of attention deficit hyperactivity disorder & Thiothalidomides and Hydroxythalidomides for the treatment of ALS and MS. Phase 2 Discovery was founded in 1998 and is headquartered in Cincinnati, OH. | - |
James Jeffery Mulchahey | M | - |
Phase 2 Discovery, Inc.
![]() Phase 2 Discovery, Inc. Pharmaceuticals: MajorHealth Technology Phase 2 Discovery, Inc. (P2D) develops central nervous system drugs. The company provides discovery research & development services for pharmaceutical and biotechnology companies. It also develops drugs for treating psychiatric and neurologic disorders. Its products include PD6735, the treatment of primary insomnia and additional indications, N-Substituted Analogs of Benztropine for the treatment of attention deficit hyperactivity disorder & Thiothalidomides and Hydroxythalidomides for the treatment of ALS and MS. Phase 2 Discovery was founded in 1998 and is headquartered in Cincinnati, OH. | - |
David A. Geracioti | M | - |
RxDino LLC
![]() RxDino LLC Pharmaceuticals: MajorHealth Technology RxDino LLC operates as a dermatology pharmaceutical company. The firm develops skin products for the treatment of dermatitis, rash, eczema, itchy, irritated skin, and allergies to plants and chemicals, such as poison ivy. It provides Over-the-counter topical hydrocortisone ointment with a formulation containing dehydroepiandrosterone as an emollient that enables hydrocortisone to be effective. The company is headquartered in Cincinnati, OH. | - |
Gregory D. Morey | M | - |
RxDino LLC
![]() RxDino LLC Pharmaceuticals: MajorHealth Technology RxDino LLC operates as a dermatology pharmaceutical company. The firm develops skin products for the treatment of dermatitis, rash, eczema, itchy, irritated skin, and allergies to plants and chemicals, such as poison ivy. It provides Over-the-counter topical hydrocortisone ointment with a formulation containing dehydroepiandrosterone as an emollient that enables hydrocortisone to be effective. The company is headquartered in Cincinnati, OH. | - |
Paul Darwish | M | - |
RxDino LLC
![]() RxDino LLC Pharmaceuticals: MajorHealth Technology RxDino LLC operates as a dermatology pharmaceutical company. The firm develops skin products for the treatment of dermatitis, rash, eczema, itchy, irritated skin, and allergies to plants and chemicals, such as poison ivy. It provides Over-the-counter topical hydrocortisone ointment with a formulation containing dehydroepiandrosterone as an emollient that enables hydrocortisone to be effective. The company is headquartered in Cincinnati, OH. | - |
Connections Chart
Multi-company connection
Statistics
Country | Connections | % of total |
---|---|---|
United States | 10 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Thomas D. Geracioti
- Personal Network